Evox Corporate PresentationAugust 22nd, 2022
Using Novel Intein Technology to Deliver Exosome-Based Therapeutics (ASGCT)May 11th – 14th, 2021
Antibody Displaying Extracellular Vesicles (Fc-EVs) for Delivery of Tumor Targeted Therapeutics (ASGCT)May 11th – 14th, 2021
Albumin-decorated Extracellular Vesicles (EVs) Demonstrate Extended Circulation Time in vivo and Exert Lymph Node-Tumour Dual Targeting (ASGCT)May 11th – 14th, 2021
Solebury Trout Private Company ShowcaseOct 15th, 2020